Autoimmune Glial Fibrillary Acidic Protein Astrocytopathy in Children: A Retrospective Analysis of 35 Cases

ObjectiveTo analyze the clinical manifestations, imaging, electroencephalography, treatment, and prognosis of 35 cases of autoimmune glial fibrillary acidic protein astrocytopathy (GFAP-A) in children.MethodsChildren hospitalized in the Department of Neurology, Hunan Children’s Hospital, China, betw...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Hongjun Fang, Wenjing Hu, Zhi Jiang, Haiyan Yang, Hongmei Liao, Liming Yang, Liwen Wu
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://doaj.org/article/d461b8e50646437d9f86892b681f128d
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:d461b8e50646437d9f86892b681f128d
record_format dspace
spelling oai:doaj.org-article:d461b8e50646437d9f86892b681f128d2021-11-22T05:13:46ZAutoimmune Glial Fibrillary Acidic Protein Astrocytopathy in Children: A Retrospective Analysis of 35 Cases1664-322410.3389/fimmu.2021.761354https://doaj.org/article/d461b8e50646437d9f86892b681f128d2021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fimmu.2021.761354/fullhttps://doaj.org/toc/1664-3224ObjectiveTo analyze the clinical manifestations, imaging, electroencephalography, treatment, and prognosis of 35 cases of autoimmune glial fibrillary acidic protein astrocytopathy (GFAP-A) in children.MethodsChildren hospitalized in the Department of Neurology, Hunan Children’s Hospital, China, between January 2015 and June 2021, owing to autoimmune diseases of the central nervous system were subjected to a cell-based assay (CBA). The assay identified 40 children positive for GFAP-immunoglobulin (Ig)G antibodies in the serum and/or the cerebrospinal fluid. Based on clinical manifestations and imaging characteristics, five children who were only positive for GFAP-IgG antibodies in serum were excluded, and the remaining 35 children were diagnosed with autoimmune GFAP-A. The clinical data derived from the 35 children were retrospectively analyzed.ResultsA total of 35 children, including 23 males and 12 females with a mean age of 6.3 ± 0.6 years, manifested clinical symptoms of fever (62.9%), headache (42.9%), convulsions (42.9%), abnormal mental behavior (51.4%), disorders of consciousness (54.3%), visual disturbance (22.9%), ataxia (11.4%), paralysis (40%), and autonomic dysfunction (25.7%). One child exhibited only the clinical symptom of peripheral facial nerve palsy. Eleven out of 35 children were also positive for other antibodies. In addition to the common overlapping autoimmune syndromes, one case of autoimmune GFAP-A also manifested as Bickerstaff’s brainstem encephalitis. Linear periventricular enhancement upon MRI was significantly less frequent in children (8.5%) than in adults. In pediatric patients, MRI contrast enhancement was principally seen in the meninges and brain lobes. Although repeated relapse (17.1%) and sequelae symptoms (20%) occurred in some cases, most children showed a favorable prognosis. Spearman’s rank correlation showed that the antibody titer was not significantly associated with the severity of the initial disease conditions.ConclusionsThe disease diagnosis in children seropositive for GFAP antibodies only should receive a comprehensive diagnosis based on their clinical symptoms, imaging, electroencephalographic characteristics, and treatment responses. Some patients with relapses should receive repeated gamma globulin and corticosteroid therapy or the addition of immunosuppressants to their therapeutic regimen, and slow-dose tapering of corticosteroids and extended treatment are recommended for patients with overlapping autoimmune syndromes.Hongjun FangWenjing HuZhi JiangHaiyan YangHongmei LiaoLiming YangLiwen WuFrontiers Media S.A.articleautoimmune glial fibrillary acidic protein astrocytopathyGFAP-IgG antibodiesoverlapping autoimmune syndromeschildrenGFAP-AImmunologic diseases. AllergyRC581-607ENFrontiers in Immunology, Vol 12 (2021)
institution DOAJ
collection DOAJ
language EN
topic autoimmune glial fibrillary acidic protein astrocytopathy
GFAP-IgG antibodies
overlapping autoimmune syndromes
children
GFAP-A
Immunologic diseases. Allergy
RC581-607
spellingShingle autoimmune glial fibrillary acidic protein astrocytopathy
GFAP-IgG antibodies
overlapping autoimmune syndromes
children
GFAP-A
Immunologic diseases. Allergy
RC581-607
Hongjun Fang
Wenjing Hu
Zhi Jiang
Haiyan Yang
Hongmei Liao
Liming Yang
Liwen Wu
Autoimmune Glial Fibrillary Acidic Protein Astrocytopathy in Children: A Retrospective Analysis of 35 Cases
description ObjectiveTo analyze the clinical manifestations, imaging, electroencephalography, treatment, and prognosis of 35 cases of autoimmune glial fibrillary acidic protein astrocytopathy (GFAP-A) in children.MethodsChildren hospitalized in the Department of Neurology, Hunan Children’s Hospital, China, between January 2015 and June 2021, owing to autoimmune diseases of the central nervous system were subjected to a cell-based assay (CBA). The assay identified 40 children positive for GFAP-immunoglobulin (Ig)G antibodies in the serum and/or the cerebrospinal fluid. Based on clinical manifestations and imaging characteristics, five children who were only positive for GFAP-IgG antibodies in serum were excluded, and the remaining 35 children were diagnosed with autoimmune GFAP-A. The clinical data derived from the 35 children were retrospectively analyzed.ResultsA total of 35 children, including 23 males and 12 females with a mean age of 6.3 ± 0.6 years, manifested clinical symptoms of fever (62.9%), headache (42.9%), convulsions (42.9%), abnormal mental behavior (51.4%), disorders of consciousness (54.3%), visual disturbance (22.9%), ataxia (11.4%), paralysis (40%), and autonomic dysfunction (25.7%). One child exhibited only the clinical symptom of peripheral facial nerve palsy. Eleven out of 35 children were also positive for other antibodies. In addition to the common overlapping autoimmune syndromes, one case of autoimmune GFAP-A also manifested as Bickerstaff’s brainstem encephalitis. Linear periventricular enhancement upon MRI was significantly less frequent in children (8.5%) than in adults. In pediatric patients, MRI contrast enhancement was principally seen in the meninges and brain lobes. Although repeated relapse (17.1%) and sequelae symptoms (20%) occurred in some cases, most children showed a favorable prognosis. Spearman’s rank correlation showed that the antibody titer was not significantly associated with the severity of the initial disease conditions.ConclusionsThe disease diagnosis in children seropositive for GFAP antibodies only should receive a comprehensive diagnosis based on their clinical symptoms, imaging, electroencephalographic characteristics, and treatment responses. Some patients with relapses should receive repeated gamma globulin and corticosteroid therapy or the addition of immunosuppressants to their therapeutic regimen, and slow-dose tapering of corticosteroids and extended treatment are recommended for patients with overlapping autoimmune syndromes.
format article
author Hongjun Fang
Wenjing Hu
Zhi Jiang
Haiyan Yang
Hongmei Liao
Liming Yang
Liwen Wu
author_facet Hongjun Fang
Wenjing Hu
Zhi Jiang
Haiyan Yang
Hongmei Liao
Liming Yang
Liwen Wu
author_sort Hongjun Fang
title Autoimmune Glial Fibrillary Acidic Protein Astrocytopathy in Children: A Retrospective Analysis of 35 Cases
title_short Autoimmune Glial Fibrillary Acidic Protein Astrocytopathy in Children: A Retrospective Analysis of 35 Cases
title_full Autoimmune Glial Fibrillary Acidic Protein Astrocytopathy in Children: A Retrospective Analysis of 35 Cases
title_fullStr Autoimmune Glial Fibrillary Acidic Protein Astrocytopathy in Children: A Retrospective Analysis of 35 Cases
title_full_unstemmed Autoimmune Glial Fibrillary Acidic Protein Astrocytopathy in Children: A Retrospective Analysis of 35 Cases
title_sort autoimmune glial fibrillary acidic protein astrocytopathy in children: a retrospective analysis of 35 cases
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/d461b8e50646437d9f86892b681f128d
work_keys_str_mv AT hongjunfang autoimmuneglialfibrillaryacidicproteinastrocytopathyinchildrenaretrospectiveanalysisof35cases
AT wenjinghu autoimmuneglialfibrillaryacidicproteinastrocytopathyinchildrenaretrospectiveanalysisof35cases
AT zhijiang autoimmuneglialfibrillaryacidicproteinastrocytopathyinchildrenaretrospectiveanalysisof35cases
AT haiyanyang autoimmuneglialfibrillaryacidicproteinastrocytopathyinchildrenaretrospectiveanalysisof35cases
AT hongmeiliao autoimmuneglialfibrillaryacidicproteinastrocytopathyinchildrenaretrospectiveanalysisof35cases
AT limingyang autoimmuneglialfibrillaryacidicproteinastrocytopathyinchildrenaretrospectiveanalysisof35cases
AT liwenwu autoimmuneglialfibrillaryacidicproteinastrocytopathyinchildrenaretrospectiveanalysisof35cases
_version_ 1718418189144031232